Prolactin receptor antagonism uncouples lipids from atherosclerosis susceptibility

Autor: Menno Hoekstra, Anne Q Reuwer, Miranda Van Eck, Vincent Goffin, Ronald J. van der Sluis, Tim van den Aardweg, Florence Boutillon, Marcel Th B Twickler
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Zdroj: The journal of endocrinology
ISSN: 0022-0795
Popis: The pituitary-derived hormone prolactin has been suggested to stimulate the development of atherosclerosis and cardiovascular disease through its effects on metabolism and inflammation. In this study, we aimed to challenge the hypothesis that inhibition of prolactin function may beneficially affect atherosclerosis burden. Hereto, atherosclerosis-susceptible LDL receptor (Ldlr) knockout mice were transplanted with bone marrow from transgenic mice expressing the pure prolactin receptor antagonist Del1-9-G129R-hPRL or their non-transgenic littermates as control. Recipient mice expressing Del1-9-G129R-hPRL exhibited a decrease in plasma cholesterol levels (−29%; PP3 μm2 for Del1-9-G129R-hPRL vs 259±32×103 μm2 for controls) and the lesional macrophage and collagen contents were not different between the two groups of bone marrow recipients. Importantly, Del1-9-G129R-hPRL exposure increased levels of circulating neutrophils (+91%; PPPPLdlr knockout mice. Despite an associated decrease in VLDL/LDL cholesterol levels, application of the prolactin receptor antagonist Del1-9-G129R-hPRL does not alter the susceptibility for initial development of atherosclerotic lesions probably due to the parallel increase in circulating leukocyte concentrations.
Databáze: OpenAIRE